Literature DB >> 29526259

Leveraging Comparative Oncology in the Hopes of Improving Therapies for Breast Cancer.

Chand Khanna1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29526259     DOI： 10.1053/j.seminoncol.2017.11.003

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  2 in total

1.  MiR-223-3p targeting epithelial cell transforming sequence 2 oncogene inhibits the activity, apoptosis, invasion and migration of MDA-MB-468 breast cancer cells.

Authors:  Xiaorui Wang; Zhongsheng Tong; Hong Liu
Journal:  Onco Targets Ther       Date:  2019-09-18       Impact factor: 4.147

2.  Identification of oncolytic vaccinia restriction factors in canine high-grade mammary tumor cells using single-cell transcriptomics.

Authors:  Béatrice Cambien; Kevin Lebrigand; Alberto Baeri; Nicolas Nottet; Catherine Compin; Audrey Lamit; Olivier Ferraris; Christophe N Peyrefitte; Virginie Magnone; Jérôme Henriques; Laure-Emmanuelle Zaragosi; Sophie Giorgetti-Peraldi; Frédéric Bost; Marine Gautier-Isola; Roger Rezzonico; Pascal Barbry; Robert Barthel; Bernard Mari; Georges Vassaux
Journal:  PLoS Pathog       Date:  2020-10-19       Impact factor: 6.823
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.